Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.600
+0.220 (15.94%)
At close: Oct 22, 2026, 4:00 PM EDT
1.519
-0.081 (-5.06%)
Pre-market: Oct 23, 2026, 4:00 AM EDT

Actinium Pharmaceuticals Revenue

Actinium Pharmaceuticals had revenue of $35.00M in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $35.09M. In the year 2025, Actinium Pharmaceuticals had annual revenue of $90.00K. That makes Actinium Pharmaceuticals the 30,360th largest company in the world by revenue and 4,023rd in the United States.

Revenue (ttm)
$35.09M
Revenue Growth
n/a
P/S Ratio
1.43
Revenue / Employee
$1,299,630
Employees
27
Market Cap
50.31M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202590.00K--
Dec 31, 2024---
Dec 31, 202381.00K-949.00K-92.14%
Dec 31, 20221.03M-114.00K-9.97%
Dec 31, 20211.14M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.